Myers-JDC-Brookdale Institute, Jerusalem, Israel.
Int J Health Plann Manage. 2011 Apr-Jun;26(2):e68-84. doi: 10.1002/hpm.1039. Epub 2010 May 4.
In 1998, Israel's national health insurance system introduced a modest co-payment for visits to specialist physicians. This study takes advantage of a natural experiment in which 15% of the population--the poor and disabled--was exempted from these co-payments. It used the micro-level panel data of three large health plans on the physician visits of 50,000 members per plan in 1997-2001. The data indicate that, following introduction of the co-payment, specialist visits increased among non-exempt members, relative to exempt members, of two health plans that together account for two-thirds of the population. This paper illustrates how, unlike the Health Insurance Experiment and other US studies of cost sharing, the structure of the co-payment in Israel may have inadvertently limited the incentive to decrease consumer demand and may have created an incentive for the health plans to increase visit rates, especially among the non-exempt members. Other countries that have implemented co-payment systems with exemptions may benefit from the Israeli experience in designing and evaluating their systems.
1998 年,以色列的国家健康保险制度对专科医生的就诊引入了适度的共付额。本研究利用了一项自然实验,其中 15%的人口——贫困人口和残疾人——被豁免了这些共付额。它使用了三个大型健康计划的微观层面面板数据,这些数据涵盖了每个计划在 1997-2001 年期间的 50,000 名成员的就诊情况。数据表明,在引入共付额后,相对于豁免成员,两个健康计划的非豁免成员的专科就诊增加了,这两个健康计划共占人口的三分之二。本文说明了与健康保险实验和美国其他成本分担研究不同的是,以色列共付额的结构可能无意中限制了减少消费者需求的激励,并且可能为健康计划创造了增加就诊率的激励,尤其是在非豁免成员中。其他实施了豁免共付额制度的国家可以从以色列在设计和评估其系统方面的经验中受益。